Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Pediatric Drugs Market?

There has been a swift increase in the pediatric drugs market dimensions in the past few years. The market, which was valued at $157 billion in 2024, is projected to increase to $179.43 billion in 2025, with a CAGR of 14.3%. The historic period’s growth is due to an increased requirement for related drugs, a higher pediatric population, more awareness about pediatric illnesses, expansion in pediatric oncology, advancements in digital health and telemedicine, and increased partnerships in the development of pediatric drugs.

The growth of the pediatric drugs market size is anticipated to surge significantly in the upcoming years, expanding to “$ 308.57 billion in 2029” with a compound annual growth rate (CAGR) of 14.5%. Factors contributing to this growth during the forecast period include a growing pediatric population, an increasing prevalence of mental health problems among children, a high incidence of chronic diseases in children, a robust vaccination rate, and an escalating demand for pediatric mental health medications. The forecast period will also witness key trends such as personalized pediatric medicine, the incorporation of technology in pediatric drug delivery, telemedicine, digital health solutions, the enhancement of pediatric clinical trials, and collaboration between pediatricians and pharmacists.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21249&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Pediatric Drugs Market?

The rise in premature births is anticipated to fuel expansion in the pediatric drugs market. Investigations have revealed that the number of infants born prior to surpassing 37 weeks of pregnancy has been increasing significantly. This trend is most likely due to multiple factors such as mature maternal age, lifestyle-related choices, pre-existing health conditions, multiple births, and insufficient prenatal care. Pediatric medications are crucial for catering to the health and developmental needs of premature infants by providing targeted therapies for issues like respiratory difficulties, infections, and nutritional deficiencies. For example, a report by Tommy’s, a charity organization in the UK, disclosed that the proportion of premature live births in England and Wales rose to 7.9% in 2022, an increase from 7.5% in the previous year. This indicates a premature birth rate of over 53,000 babies in 2022. Therefore, the increasing trend in premature births is contributing to the growth of the pediatric drugs market.

How Is The Pediatric Drugs Market Organized By Different Segments?

The pediatric drugs market covered in this report is segmented –

1) By Type: Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs, Cardiovascular Drugs

2) By Route Of Administration: Oral, Topical, Parenteral, Other Route Of Administrations

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Respiratory Disorder Drugs: Asthma Medications, Cystic Fibrosis Treatments, Bronchodilators, Corticosteroids

2) By Autoimmune Disorder Drugs: Immunosuppressants, Biologic Therapies, Disease-Modifying Antirheumatic Drugs (DMARDs)

3) By Gastrointestinal Drugs: Proton Pump Inhibitors (PPIs), Antiemetics, Antidiarrheals, Laxatives

4) By Cardiovascular Drugs: Antihypertensive Medications, Heart Failure Treatments, Antiarrhythmic Drugs, Lipid-lowering Agents

What Current And Upcoming Trends Are Shaping The Pediatric Drugs Market?

Major companies involved in the pediatric drugs market are directing their focus towards the development of novel drugs like completely human monoclonal antibodies. The aim is to elevate treatment outcomes and minimize the side effects for young patients. Fully human monoclonal antibodies are a product of human genetic sequences, reducing the potential for immune system reactions as opposed to chimeric or humanized monoclonal antibodies. These antibodies are created with the use of cutting-edge biotechnology techniques, such as transgenic mice embedded with human antibody genes or phage display technology. For instance, in August 2022, Johnson and Johnson, a pharmaceutical firm based in the US, obtained FDA approval for STELARA (ustekinumab), a treatment for pediatric patients aged six and above diagnosed with active psoriatic arthritis (PsA). This approval represents a major breakthrough as STELARA is the first biologic therapy to target interleukin-12 (IL-12) and interleukin-23 (IL-23), crucial cytokines relevant to inflammatory responses connected with autoimmune diseases. About 5-8% of children with chronic inflammatory arthritis suffer from active PsA, presenting symptoms like joint swelling and skin lesions.

Who Are The Primary Market Leaders In The Pediatric Drugs Market?

Major companies operating in the pediatric drugs market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Co., Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Vertex Pharmaceuticals, UCB Pharma, Sun Pharmaceutical Industries Ltd., Perrigo Company, Shionogi & Co. Ltd., Mallinckrodt, Torrent Pharmaceuticals Ltd, Sarepta Therapeutics, Zydus Cadila

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pediatric-drugs-global-market-report

How Do Regional Dynamics Influence The Pediatric Drugs Market Performance?

North America was the largest region in the pediatric drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21249&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model